Gene Symbol | LIF |
Entrez ID | 3976 |
Uniprot ID | P15018 |
Description | leukemia inhibitory factor |
Chromosomal Location | chr22: 30,240,447-30,246,851 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001974 |
blood vessel remodeling |
The reorganization or renovation of existing blood vessels. |
IEA |
BP |
GO:0006955 |
immune response |
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
IEA |
BP |
GO:0007275 |
multicellular organism development |
The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult). |
TAS |
BP |
GO:0007566 |
embryo implantation |
Attachment of the blastocyst to the uterine lining. |
IEA |
BP |
GO:0008284 |
positive regulation of cell proliferation |
Any process that activates or increases the rate or extent of cell proliferation. |
IDA |
BP |
GO:0008285 |
negative regulation of cell proliferation |
Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
IEA |
BP |
GO:0019827 |
stem cell population maintenance |
The process by which an organism or tissue maintains a population of stem cells of a single type. This can be achieved by a number of mechanisms: stem cell asymmetric division maintains stem cell numbers; stem cell symmetric division increases them; maintenance of a stem cell niche maintains the conditions for commitment to the stem cell fate for some types of stem cell; stem cells may arise de novo from other cell types. |
IEA |
BP |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation |
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
IDA |
BP |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein |
Any process that activates or increases the frequency, rate or extent of the phosphorylation of a serine residue of a STAT (Signal Transducer and Activator of Transcription) protein. |
IDA |
BP |
GO:0042503 |
tyrosine phosphorylation of Stat3 protein |
The process of introducing a phosphate group to a tyrosine residue of a Stat3 protein. |
IEA |
BP |
GO:0042511 |
positive regulation of tyrosine phosphorylation of Stat1 protein |
Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a Stat1 protein. |
IDA |
BP |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein |
Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a Stat3 protein. |
IDA |
BP |
GO:0043410 |
positive regulation of MAPK cascade |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade. |
IDA |
BP |
GO:0045651 |
positive regulation of macrophage differentiation |
Any process that activates or increases the frequency, rate or extent of macrophage differentiation. |
IDA |
BP |
GO:0045835 |
negative regulation of meiotic nuclear division |
Any process that stops, prevents, or reduces the frequency, rate or extent of meiosis. |
IEA |
BP |
GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
IDA |
BP |
GO:0046697 |
decidualization |
The cellular and vascular changes occurring in the endometrium of the pregnant uterus just after the onset of blastocyst implantation. This process involves the proliferation and differentiation of the fibroblast-like endometrial stromal cells into large, polyploid decidual cells that eventually form the maternal component of the placenta. |
IEA |
BP |
GO:0046888 |
negative regulation of hormone secretion |
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of a hormone from a cell. |
IDA |
BP |
GO:0048286 |
lung alveolus development |
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways. |
IEA |
BP |
GO:0048644 |
muscle organ morphogenesis |
The process in which the anatomical structures of muscle are generated and organized. |
IEA |
BP |
GO:0048666 |
neuron development |
The process whose specific outcome is the progression of a neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. |
IEA |
BP |
GO:0048711 |
positive regulation of astrocyte differentiation |
Any process that activates or increases the frequency, rate or extent of astrocyte differentiation. |
IEA |
BP |
GO:0048861 |
leukemia inhibitory factor signaling pathway |
Any series of molecular signals initiated by the binding of leukemia inhibitory factor to a receptor on the surface of the target cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
IDA |
BP |
GO:0048863 |
stem cell differentiation |
The process in which a relatively unspecialized cell acquires specialized features of a stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells. |
IEA |
BP |
GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation |
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
IDA |
BP |
GO:0060426 |
lung vasculature development |
The biological process whose specific outcome is the progression of a lung vasculature from an initial condition to its mature state. This process begins with the formation of the lung vasculature and ends with the mature structure. The lung vasculature is composed of the tubule structures that carry blood or lymph in the lungs. |
IEA |
BP |
GO:0060463 |
lung lobe morphogenesis |
The process in which the anatomical structures of a lung lobe are generated and organized. A lung lobe is a projection that extends from the lung. |
IEA |
BP |
GO:0060707 |
trophoblast giant cell differentiation |
The process in which a relatively unspecialized cell acquires specialized features of a trophoblast giant cell of the placenta. Trophoblast giant cells are the cell of the placenta that line the maternal decidua. |
IEA |
BP |
GO:0060708 |
spongiotrophoblast differentiation |
The process in which a relatively unspecialized cell of the ectoplacental cone acquires specialized features of a spongiotrophoblast of the placenta. A spongiotrophoblast cell is a basophilic cell. |
IEA |
BP |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade |
Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
IEA |
BP |
GO:0072108 |
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
Any process that increases the rate, frequency or extent of the transition where a mesenchymal cell establishes apical/basolateral polarity, forms intercellular adhesive junctions, synthesizes basement membrane components and becomes an epithelial cell that will contribute to the shaping of the metanephros. |
IDA |
BP |
GO:0072307 |
regulation of metanephric nephron tubule epithelial cell differentiation |
Any process that modulates the frequency, rate or extent of metanephric nephron tubule epithelial cell differentiation. |
IDA |
BP |
GO:1900182 |
positive regulation of protein localization to nucleus |
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus. |
IDA |
BP |
GO:1901676 |
positive regulation of histone H3-K27 acetylation |
Any process that activates or increases the frequency, rate or extent of histone H3-K27 acetylation. |
IDA |
BP |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
Any process that modulates the frequency, rate or extent of RNA polymerase II regulatory region sequence-specific DNA binding. |
IEA |
CC |
GO:0005576 |
extracellular region |
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
TAS |
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IC |
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IDA |
MF |
GO:0001135 |
transcription factor activity, RNA polymerase II transcription factor recruiting |
The function of binding to an RNA polymerase II (RNAP II) transcription factor and recruiting it to the transcription machinery complex in order to modulate transcription by RNAP II. |
IDA |
MF |
GO:0005102 |
receptor binding |
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
IPI |
MF |
GO:0005125 |
cytokine activity |
Functions to control the survival, growth, differentiation and effector function of tissues and cells. |
IDA |
MF |
GO:0005146 |
leukemia inhibitory factor receptor binding |
Interacting selectively and non-covalently with the leukemia inhibitory factor receptor. |
IDA|IPI |
MF |
GO:0008083 |
growth factor activity |
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
IDA |
Domain ID | Description |
---|---|
IPR001581 |
Leukemia inhibitory factor /oncostatin |
IPR003624 |
Leukemia inhibitory factor |
IPR009079 |
Four-helical cytokine-like, core |
IPR019827 |
Leukemia inhibitory factor /oncostatin, conserved site |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04060 |
Cytokine-cytokine receptor interaction |
KEGG |
hsa04550 |
Signaling pathways regulating pluripotency of stem cells |
KEGG |
hsa04630 |
Jak-STAT signaling pathway |
KEGG |
hsa04668 |
TNF signaling pathway |
KEGG |
WP560 |
TGF-beta Receptor Signaling |
WikiPathways |
WP236 |
Adipogenesis |
WikiPathways |
WP3931 |
ESC Pluripotency Pathways |
WikiPathways |
WP1544 |
MicroRNAs in cardiomyocyte hypertrophy |
WikiPathways |
h_nfatPathway |
NFAT and Hypertrophy of the heart (Transcription in the broken heart) |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0000786 |
Spontaneous Abortion |
C0017661 |
Iga Glomerulonephritis |
C0018800 |
Cardiomegaly |
C0021361 |
Female Infertility |
C0400966 |
Non-Alcoholic Fatty Liver Disease |
C0752351 |
Embryo Loss |
C1262477 |
Weight Decreased |
C1720887 |
Female Urogenital Diseases |
Database Name |
---|
DisGeNET |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
IL6ST |
3572 |
P40189 |
0.86 |
LIFR |
3977 |
P42702 |
0.96 |